What is Felix?
Founded in 2019 and headquartered in Toronto, Ontario, Felix operates as an end-to-end digital health platform. The company streamlines the patient experience by facilitating online consultations with licensed Canadian physicians for lifestyle medications. By integrating a seamless prescription process with an automated, reliable shipping schedule, Felix addresses critical friction points in traditional pharmacy models. Its market position is defined by its focus on convenience, accessibility, and the digitization of routine medical care, effectively positioning itself as a leader in the burgeoning Canadian healthtech sector.
How much funding has Felix raised?
Felix has raised a total of $21.3M across 2 funding rounds:
Series A
$7.9M
Series B
$13.4M
Series A (2021): $7.9M with participation from BrandProject, H Ventures, Whitecap Venture Partners, and Mantella Venture Partners
Series B (2023): $13.4M led by Mantella Venture Partners, Whitecap Venture Partners, Canadian Business Growth Fund, and BDC Capital Management
Key Investors in Felix
Mantella Venture Partners
Mantella Venture Partners is an investment firm focused on early-stage software companies in high-growth markets, providing hands-on support to entrepreneurs throughout their growth journey.
Whitecap Venture Partners
Whitecap Venture Partners is a Toronto-based early-stage venture capital fund investing in high-growth companies across ICT, MedTech, and FoodTech verticals.
Canadian Business Growth Fund
The Canadian Business Growth Fund provides long-term, minority capital to privately-owned Canadian businesses, supported by the nation's leading banks and insurance companies.
What's next for Felix?
With the successful closure of its latest financing round, Felix is well-positioned to accelerate its operational expansion and enhance its technological infrastructure. The infusion of capital will likely be directed toward scaling its patient acquisition strategies, optimizing its automated supply chain, and potentially broadening its therapeutic offerings. As the company moves into this next phase of growth, it will continue to leverage the expertise of its institutional backers to navigate regulatory landscapes and solidify its footprint in the competitive telemedicine space. The focus remains on maintaining high standards of care while scaling the platform to meet the increasing demand for digital-first healthcare solutions across Canada.
See full Felix company page
